| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |